secwatch.observer — SEC 8-K summary
======================================

Issuer:     ALX ONCOLOGY HOLDINGS INC (ALXO)
CIK:        0001810182
Form:       8-K
Filed at:   2026-10-15T20:55:47+00:00
Accession:  0001193125-26-422992
Event type: other_material
Sentiment:  neutral
Materiality: 0.45
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

ALX Oncology swaps 13.35M shares from Blackstone, RA Capital, venBio for $0.001 pre-funded warrants
--------------------------------------------------------------------------------

- Stockholders surrender 13,353,384 common shares for no consideration; ALX issues pre-funded warrants for the same 13,353,384 shares at a $0.001 exercise price.
- Blackstone Annex Master Fund surrenders 12,885,891 shares; RA Capital Healthcare Fund 213,667 shares; venBio Global Strategic Fund 253,826 shares.
- Exchange made under Section 3(a)(9) registration exemption; settlement on or about October 15, 2026, with Computershare instructed to cancel or re-register the shares.
- Warrants exercisable at any time for cash or cashless; 4.99%/9.99% beneficial ownership blockers, adjustable up to 19.99% effective 61 days after holder notice.
- Company confirms no commissions or remuneration were paid to solicit the exchange; warrants and warrant shares may carry restrictive legends.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1810182/000119312526422992/0001193125-26-422992-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1810182/000119312526422992/alxo-20261014.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-422992

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer